Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/08/2007 | WO2007027315A2 A biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart |
03/08/2007 | WO2007027289A1 Shear thinning polymer cell delivery compositions |
03/08/2007 | WO2007027226A2 Systems and methods for the production of differentiated cells |
03/08/2007 | WO2007027157A1 Method of deriving progenitor cell line |
03/08/2007 | WO2007027156A1 Method of deriving mesenchymal stem cells |
03/08/2007 | WO2007027132A1 Treatment of inflammatory bowel disease |
03/08/2007 | WO2007026698A1 Gene causative of the aging smell of malt drink and utilization of the same |
03/08/2007 | WO2007026661A1 Method for specifically selecting antibody-producing cell |
03/08/2007 | WO2007026617A1 Expression vector, transformant having the expression vector introduced therein, and process for production of heterologous protein |
03/08/2007 | WO2007026255A2 Dedifferentiated cells and methods of making and using dedifferentiated cells |
03/08/2007 | WO2007025705A2 Method for the generation of antigen-specific t-cells and uses thereof |
03/08/2007 | WO2007025554A1 Method for the generation of antigen-specific t-cells and uses thereof |
03/08/2007 | WO2007025388A2 Anti-apoptotic protein antibodies |
03/08/2007 | WO2007025385A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
03/08/2007 | WO2006128029A3 Production of osteoclasts from adipose tissues |
03/08/2007 | WO2006127712A3 Compositions and methods for inducing, stimulating and directing neuronal growth |
03/08/2007 | WO2006120575A3 Tcr-independent activation of t cells with co-lignation of cd28 and cd81 |
03/08/2007 | WO2006117237A3 Regeneration system, its production and use |
03/08/2007 | WO2006113382A3 Bioreactor system and method of enhancing functionality of muscle cultured in vitro |
03/08/2007 | WO2006110760A3 Compositions and methods for the diagnosis and treatment of tumor |
03/08/2007 | WO2006081435A3 Method of providing readily available cellular material derived from cord blood, and a composition thereof |
03/08/2007 | WO2006076627A3 Methods and compositions related to modulating the extracellular stem cell environment |
03/08/2007 | WO2006070370A3 Stem cells culture systems |
03/08/2007 | WO2006014816A3 Canis sphingosine 1-phosphate receptor isoform 2 |
03/08/2007 | WO2006014157A9 Methods of using regenerative cells to promote wound healing |
03/08/2007 | WO2004076642A3 Method for modulating epithelial stem cell lineage |
03/08/2007 | WO2004050841A3 Casein kinase i epsilon and casein kinase i delta and sleep in humans |
03/08/2007 | WO2004003137A3 Method for suppression or reversing of cellular aging |
03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
03/08/2007 | US20070056060 Transforming a plant cell with a nucleic acid sequence that encodes the acquired resistance polypeptide, regenerating a plant from the transformed plant cell; resistance to fungal pathogens |
03/08/2007 | US20070056057 Methods and means for obtaining modified phenotypes |
03/08/2007 | US20070056054 Model for muscular dystrophy and cardiomyopathy |
03/08/2007 | US20070056053 Glucosidases, nucleic acids encoding them and methods for making and using them |
03/08/2007 | US20070056051 Expression system for insect pest control |
03/08/2007 | US20070055457 Method for the evolutionary design of biochemical reaction networks |
03/08/2007 | US20070055367 Medical device with coating that promotes endothelial cell adherence and differentiation |
03/08/2007 | US20070055050 Methods and reagents for diagnosis and treatment of diabetes |
03/08/2007 | US20070054860 Use of human chorionic gonadotropin (hCG)-derived peptides; reperfusion injuries; NF-kappa B-down-regulating peptide |
03/08/2007 | US20070054845 Which block binding of polypeptides; treatment of metabolic disorders such as obesity, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
03/08/2007 | US20070054399 differentiating and proliferating a mesenchymal stem cell into the neural cell by culturing in a medium comprising an epidermal growth factor and a hepatocyte growth factor after confluent culture of the mesenchymal stem cell |
03/08/2007 | US20070054398 Human salivary gland-origin stem cell |
03/08/2007 | US20070054397 Adult cardiac uncommitted progenitor cells |
03/08/2007 | US20070054396 Cell line and methods for determining viral titer |
03/08/2007 | US20070054394 Using adenoviral vector as tool in expression of erythropoietin in cells |
03/08/2007 | US20070054378 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
03/08/2007 | US20070054364 Polypeptide variants |
03/08/2007 | US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
03/08/2007 | US20070054362 Recombinant production of mixtures of antibodies |
03/08/2007 | US20070054361 Compositions and methods for the diagnosis and treatment of tumor |
03/08/2007 | US20070054356 Glycine-rich proteins, their coding genes and applications |
03/08/2007 | US20070054355 Cbl-b polypeptides, complexes and related methods |
03/08/2007 | US20070054290 Bind to hedgehog polypeptides with high affinity; exhibit spatially and temporally restricted expression domains indicative of important roles in hedgehog-mediated induction |
03/08/2007 | US20070054284 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
03/08/2007 | US20070054258 Method of removing mucus and cell treatment solution and preservative solution used therefor |
03/08/2007 | US20070053935 Nucleotide sequences coding HEV (hemorrhagic enteritis virus) or EDS (egg drop syndrome virus) capsid proteins for use in vaccinating domestic birds against pathogenic adenoviral infection |
03/08/2007 | US20070053922 Epitope based vaccines directed towards HPV; side effect reduction; vaccination |
03/08/2007 | US20070053915 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
03/08/2007 | US20070053912 Compounds for neutralizing the effects of secreted pla2iia |
03/08/2007 | US20070053908 Uses of human zven antagonists |
03/08/2007 | US20070053907 Uses of human zven antagonists |
03/08/2007 | US20070053902 Anti-alphabeta3 humanized monoclonal antibodies |
03/08/2007 | US20070053890 Canine embryonic stem cells |
03/08/2007 | US20070053889 Il-10 gene transfer to peripheral mononuclear cells |
03/08/2007 | US20070053888 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
03/08/2007 | US20070053887 Method for production of neuroblasts |
03/08/2007 | US20070053886 Biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart |
03/08/2007 | US20070053885 Mesenchymal stem cell |
03/08/2007 | US20070053884 Novel adult tissue-derived stem cell and use thereof |
03/08/2007 | US20070053883 Neuronal cell lineages and methods of production thereof |
03/08/2007 | US20070053873 Canine tumor treatment method, pharmaceutical formulation applied thereto, and method of cryogenically preserving cells used therewith |
03/08/2007 | CA2625951A1 Anti-apoptotic protein antibodies |
03/08/2007 | CA2621157A1 Osteogenic and anti-adipogenic oxysterols |
03/08/2007 | CA2620935A1 Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport |
03/08/2007 | CA2620912A1 Stress tolerance in plants |
03/08/2007 | CA2620897A1 Eg8798 and eg9703 polynucleotides and uses thereof |
03/08/2007 | CA2620862A1 Insect resistant transgenic turf grass |
03/08/2007 | CA2620515A1 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
03/08/2007 | CA2620351A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
03/08/2007 | CA2619735A1 Treatment of inflammatory bowel disease |
03/07/2007 | EP1760158A1 Method of assaying substance capable of changing mitochondrial membrane potential |
03/07/2007 | EP1760155A2 Non-human sperm-DNA complexes for geneticallly modifying non-human animals |
03/07/2007 | EP1760154A2 sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell |
03/07/2007 | EP1760151A1 An improved method for the production and purification of adenoviral vectors |
03/07/2007 | EP1760148A1 AMP DEAMINASE ORIGINATING IN STREPTOMYCES<i> </i>AND UTILIZATION THEREOF |
03/07/2007 | EP1760146A2 Protein kinase stress-related proteins and methods of use in plants |
03/07/2007 | EP1760144A2 Cartilage and bone repair composition |
03/07/2007 | EP1760092A1 System for screening cells for high expression of a protein of interest |
03/07/2007 | EP1759720A1 Artificial blood vessel and process for producing the same |
03/07/2007 | EP1759709A1 Humanized antibodies against leukocyte adhesion molecule VLA-4 |
03/07/2007 | EP1759582A1 Preservative solution for cells, tissues and organs comprising rare sugar and presercation method with the use of the same |
03/07/2007 | EP1759536A2 In vitro techniques for use with stem cells |
03/07/2007 | EP1759002A2 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
03/07/2007 | EP1758997A1 Episomal fusion gene |
03/07/2007 | EP1758989A2 Therapeutic reprogramming, hybrid stem cells and maturation |
03/07/2007 | EP1758988A2 Stem cell maturation for all tissue lines |
03/07/2007 | EP1758987A1 Methods for stem cell expansion and differentiation |
03/07/2007 | EP1758986A2 Neural stem cells |
03/07/2007 | EP1758985A2 Artificial immune system: methods for making and use |
03/07/2007 | EP1758984A2 Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof |
03/07/2007 | EP1758929A2 Methods for altering protein production rates |